SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-059250
Filing Date
2020-11-18
Accepted
2020-11-18 19:19:42
Documents
1
Period of Report
2020-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11320
  Complete submission text file 0001209191-20-059250.txt   12922
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Issuer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HATTERAS VENTURE PARTNERS III, LP 280 S. MANGUM ST., SUITE 350 DURHAM NC 27701
Business Address
Thorp Clay (Reporting) CIK: 0001592380 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38697 | Film No.: 201326615